- Companies
- Hong Kong Asia Heart Centre
Hong Kong Asia Heart Centre Funding, Investors & Competitors
Hong Kong Asia Heart Centre has raised $550M across 2 funding rounds, most recently a $400M Series D in February 2022.
Last Hong Kong Asia Heart Centre funding round
$400M
Series D · Feb 2022
Cumulative funding Hong Kong Asia Heart Centre raised
$550M
across 2 funding rounds
Key investors in Hong Kong Asia Heart Centre
General Atlantic
Legend Capital
Primavera Capital Group
BOCOM Intl Hldgs Co
Country Garden Venture Capital
Taikang Insurance Group
ABC International
Hudson Bay Capital Management
Hong Kong Asia Heart Centre Overview
About Hong Kong Asia Heart Centre
Hong Kong Asia Heart Centre is a specialist cardiovascular clinic chain with locations in Kowloon and Hong Kong Island since 1999. It offers non-invasive diagnostics like CT angiography, echocardiography, and Holter monitoring alongside angioplasty and pacemaker implants. The team performs over 2,000 procedures yearly, treating coronary artery disease for patients from mainland China and Southeast Asia.
Founded
1999
HQ
Website
Status
Privately held
Customer focus
B2C
Revenue model
Services
Sectors
Hong Kong Asia Heart Centre Funding History
Hong Kong Asia Heart Centre has raised a total of $550M across 2 funding rounds.
Hong Kong Asia Heart Centre's first fundraising round was a $150M strategic investment round in September 2018. The most recent completed round was a $400M Series D in February 2022.
Hong Kong Asia Heart Centre funding rounds
| Date | Stage | Investors | Raised | Deal Summary |
|---|---|---|---|---|
| Feb 2022 | Series D | Country Garden Venture Capital (lead); Primavera Capital Group (lead); ICBC International; BOCOM Intl Hldgs Co; Taikang Insurance Group; Hudson Bay Capital Management; ABC International; General Atlantic; Sherpa Ventures; Legend Capital | $400M | Hong Kong Asia Heart Centre (also referred to as Hong Kong Asia Medical Group in some sources) is a cardiovascular specialist chain founded in 1999, providing various cardiovascular assessment and surgical services with a professional medical team experienced in heart disease treatment. In 2022, the company raised a USD400m Series D round led by Country Garden Venture Capital and Primavera Capital Group, with participation from Taikang Life Insurance (Taikang Insurance Group), ICBC International, ABC International, BOCOM International (BOCOM Intl Hldgs Co), Hudson Bay Capital, Sherpa Venture Capital (Sherpa Ventures), and follow-on investments from Legend Capital and General Atlantic. The investment supports the hospital chain's growth in the healthcare sector, focusing on specialized cardiac care in Hong Kong and potentially broader Asia. The deal highlights interest from prominent China-based and international investors in Asian healthcare, particularly specialized hospitals amid regional medical demands. |
| Sep 2018 | Strategic investment | General Atlantic (lead) | $150M | - |
Who has invested in Hong Kong Asia Heart Centre?
10 investors have backed Hong Kong Asia Heart Centre across its funding rounds, including General Atlantic, Legend Capital, Primavera Capital Group, BOCOM Intl Hldgs Co, Country Garden Venture Capital and Taikang Insurance Group.
Lead investors include Country Garden Venture Capital, Primavera Capital Group and General Atlantic.
Hong Kong Asia Heart Centre Investors
| Investor | HQ | Rounds | Role | First check |
|---|---|---|---|---|
| 2 | Lead | Sep 2018 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
| 1 | Lead | Feb 2022 | ||
| 1 | Participant | Feb 2022 | ||
This data is available for Pro users. Sign up to see all 10 Hong Kong Asia Heart Centre investors. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialHong Kong Asia Heart Centre Competitors
Hong Kong Asia Heart Centre competitors include listed companies like HCA Healthcare, Alcon, Fresenius and Dr. Sulaiman Al Habib, and private ones like IVC Evidensia and Luz Saude.
| Company | HQ | Status | Revenue | EBITDA | Valuation | Revenue Multiple |
|---|---|---|---|---|---|---|
| Publicly listed | $76B | $16B | $93B | 1.9x | ||
| Publicly listed | $10B | $2.6B | $31B | 3.3x | ||
| Publicly listed | $26B | $4.2B | $30B | 1.6x | ||
| Publicly listed | $3.7B | $927M | $21B | 5.9x | ||
| Private | - | - | $14B | - | ||
| Private | - | $333M | $3.2B | - |
Hong Kong Asia Heart Centre Public Comps
Hong Kong Asia Heart Centre is still privately-owned, but its public comps include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, Tenet Healthcare, IHH Healthcare, Rede D'Or São Luiz, Apollo Hospitals, Encompass Health and DaVita.
| Last FY | EV/Revenue | EV/EBITDA | ||||||
|---|---|---|---|---|---|---|---|---|
| Revenue | EBITDA | Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| $76B | $16B | 1.9x | 1.9x | 9.4x | 9.4x | |||
| $10B | $2.6B | 3.4x | 3.3x | 13.4x | 12.5x | |||
| $26B | $4.2B | 1.6x | 1.6x | 10.1x | 9.4x | |||
| $3.7B | $927M | 6.4x | 5.9x | 25.2x | 24.7x | |||
| $21B | $4.5B | 1.7x | 1.6x | 8.1x | 7.5x | |||
| $6.3B | $1.5B | 3.3x | 3.0x | 13.8x | 13.6x | |||
| $11B | $1.3B | 1.7x | 1.6x | 14.3x | 8.4x | |||
| $2.6B | $398M | 5.3x | 4.9x | 34.9x | 32.1x | |||
This data is available for Pro users. Sign up to see all Hong Kong Asia Heart Centre competitors and their valuation data. Start Free Trial | ||||||||
Common questions about Hong Kong Asia Heart Centre
| When was Hong Kong Asia Heart Centre founded? | Hong Kong Asia Heart Centre was founded in 1999. |
| Where is Hong Kong Asia Heart Centre headquartered? | Hong Kong Asia Heart Centre is headquartered in Hong Kong, Hong Kong. |
| Is Hong Kong Asia Heart Centre publicly listed? | No, Hong Kong Asia Heart Centre is a private, VC-backed company. |
| How much funding has Hong Kong Asia Heart Centre raised? | Hong Kong Asia Heart Centre has raised $550M across 2 funding rounds. |
| What was Hong Kong Asia Heart Centre's last funding round? | Hong Kong Asia Heart Centre's last funding round was a $400M Series D in February 2022, led by Country Garden Venture Capital and Primavera Capital Group. |
| Who are Hong Kong Asia Heart Centre's investors? | Hong Kong Asia Heart Centre's investors include General Atlantic, ICBC International, BOCOM Intl Hldgs Co, Taikang Insurance Group, Hudson Bay Capital Management, ABC International, Primavera Capital Group, Sherpa Ventures, Legend Capital and Country Garden Venture Capital. |
| Which companies are comparable to Hong Kong Asia Heart Centre? | Companies comparable to Hong Kong Asia Heart Centre include HCA Healthcare, Alcon, Fresenius, Dr. Sulaiman Al Habib, IVC Evidensia and Luz Saude. |
See companies similar to Hong Kong Asia Heart Centre
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.




